HC Wainwright & Co. Maintains Buy on Precision BioSciences, Lowers Price Target to $3
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Patrick Trucchio maintains a 'Buy' rating on Precision BioSciences (NASDAQ:DTIL) but lowers the price target from $5 to $3.
August 17, 2023 | 10:23 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Precision BioSciences' price target has been lowered from $5 to $3 by HC Wainwright & Co., though the 'Buy' rating is maintained.
The lowering of the price target by HC Wainwright & Co. indicates a potential decrease in the short-term value of Precision BioSciences' stock. However, the maintained 'Buy' rating suggests that the company is still seen as a good investment in the long term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100